首页> 外国专利> THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 AND OTHER CYTOKINE STORM ASSOCIATED DISORDERS

THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 AND OTHER CYTOKINE STORM ASSOCIATED DISORDERS

机译:用于治疗Covid-19和其他细胞因子暴风相关疾病的治疗组合物

摘要

It is disclosed a therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders, wherein the therapeutic composition comprises at least one active agent being selected from the following active agent groups a) to e):a) complement factor 3-targeting inhibitor of complement activation cascadeb) carboxypeptidase B enzymec) complement factor 5a receptor-targeting inhibitor of complement activation cascaded) endothelin A receptor-targeting inhibitor of extravasatione) bone morphogenic protein.;It is further disclosed a method of treating COVID-19 and other cytokine storm associated disorders, wherein said method comprises administering an effective amount of at least one active agent being selected from the above mentioned active agent groups a) to e).
机译:公开了一种用于治疗Covid-19和其他细胞因子暴雨相关疾病的治疗组合物,其中治疗组合物包含至少一种选自下列活性剂基团A)至e)的活性剂:a)补体因子 3-靶向靶向抑制剂的补体激活酶促抑制剂)羧肽酶B enzymec)补体系数5A受体靶向抑制剂的补体激活级联)内皮素外向的受体靶向抑制剂的骨形态发生蛋白。[还公开了一种治疗Covid-19的方法 和其他细胞因子暴雨相关疾病,其中所述方法包括施用从上述活性剂基团A)至E)的有效量的至少一种活性剂。

著录项

  • 公开/公告号US2021386821A1

    专利类型

  • 公开/公告日2021-12-16

    原文格式PDF

  • 申请/专利权人 KELSIUS LABORATORIES LLC;

    申请/专利号US202016898378

  • 发明设计人 LAJOS BARANYI;

    申请日2020-06-10

  • 分类号A61K38/17;C12N15/86;A61K38/18;A61K38/48;

  • 国家 US

  • 入库时间 2022-08-24 22:52:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号